<DOC>
	<DOC>NCT01809964</DOC>
	<brief_summary>The purpose of this study is to confirm the effect of ANT-1401 in the treatment of Lateral Canthal Lines.</brief_summary>
	<brief_title>Clinical Trial to Evaluate ANT-1401 in Crow's Feet</brief_title>
	<detailed_description />
	<criteria>30 60 years of age mild to moderate Crow's Feet wrinkles (IGA 12) at rest moderate to severe Crow's Feet (IGA 23) on contraction moderate to severe Crow's Feet (SSA 23) on contraction Have adequate vision to assess facial wrinkles in a mirror botulinum toxin treatment in the prior 6 months history of periocular surgery, brow lift or related procedures soft tissue augmentation in the lateral canthal region in the prior 12 months dermabrasion or laser treatment in the periocular region in the last 6 months topical prescriptionstrength retinoids in the prior 3 months present or history of neuromuscular disease present or history of "dry eye" systemic aminoglycoside use in the week prior to treatment application</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>